AIN
Kitsa Seed Round

Kitsa Seed Round

location_on Midwest ,  United States

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Kitsa is using Agentic AI to transform how pharma launches clinical trials, cutting 6–8 months off timelines and saving $6–$12M per study through an AI-powered Site Network that matches the right sites and patients faster.

Highlights

  • Massive, Proven Problem: Efficiency play in a $80B industry
  • Agentic AI automates start-up, saves 6–8 months, $6–$12M.
  • Ex-AWS founders, built trial solutions for Top-20 pharma.
  • AI-powered Site Network with deep first-party data moat.
  • J&J Flagship customer with strong partner-led sales motion

Overview

Target A$750,000
Minimum A$40,000
Investment Raised A$150,000
Previous Rounds A$1,100,000
Stage Achieving Sales
Investor Role Monthly Involvement

Ask a question
Got a question about this project?

Similar Projects